Overview
SNWV market data
Price History
SNWV price chart · 1M
- O
- 4.84
- H
- 4.84
- L
- 4.66
- C
- 4.66
- Vol
- 3,727.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $4.84
- Previous Close
- $4.86
- Day High
- $4.84
- Day Low
- $4.66
- 52 Week High
- $20.08
- 52 Week Low
- $4.50
- 7 Day Return
- -5.48%
- 30 Day Return
- -26.73%
- 90 Day Return
- -72.12%
- 1 Year Return
- -71.93%
- Daily Notional Volume
- $17.4K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 2.56 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $1.30 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.45 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 36.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $4.50 – $44.94 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $41M · P/B 158.07 · P/S 0.93.
Company News
Sanuwave Announces Q2 FY2026 Financial ResultsGlobenewswire Inc · Aug 6, 2026, 9:15 PM
8-K filing — SANUWAVE Health, Inc. (SNWV)SEC EDGAR · Aug 6, 2026, 9:07 PM
SANUWAVE Health Q2 EPS $(0.08) Down From $(0.04) YoY, Sales $9.739M Down From $10.054M YoYBenzinga · Aug 6, 2026, 8:42 PM
What's Going on With SANUWAVE Health Stock on Friday?Benzinga · Jul 17, 2026, 1:42 PM
SANUWAVE Health Raises Q2 Sales Guidance from $8.500M-$9.500M to $9.600M-$9.800MBenzinga · Jul 13, 2026, 8:48 PM
SANUWAVE Health Raises Prelim. Q2 Revenue From $8.5M-$9.5M To $9.6M-$9.8MBenzinga · Jul 13, 2026, 8:33 PM
Sanuwave Health Expects Q2 Revenue Range $8.5M - $9.5MBenzinga · Jun 16, 2026, 12:15 PM